Qiagen NV
LSE:0RLT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Q
|
Qiagen NV
LSE:0RLT
|
NL |
|
Embotelladora Andina SA
NYSE:AKO.A
|
CL |
|
C
|
Charles River Laboratories International Inc
F:RV6
|
US |
|
T
|
Teekay Tankers Ltd
LSE:0EAQ
|
CA |
|
Giken Ltd
TSE:6289
|
JP |
|
P
|
Perusahaan Gas Negara Tbk PT
XBER:PGB1
|
ID |
|
V
|
Vext Science Inc
XMUN:VV5
|
CA |
|
L
|
LKQ Corp
LSE:0JSJ
|
US |
Wall St Price Targets
0RLT Price Targets Summary
Qiagen NV
According to Wall Street analysts, the average 1-year price target for 0RLT is 38.0658 EUR with a low forecast of 31.5692 EUR and a high forecast of 52.6839 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0RLT's stock price target?
Price Target
38.0658
EUR
According to Wall Street analysts, the average 1-year price target for 0RLT is 38.0658 EUR with a low forecast of 31.5692 EUR and a high forecast of 52.6839 EUR.
What is the Revenue forecast for Qiagen NV?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 5 years is 6%.
What is the Operating Income forecast for Qiagen NV?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 5 years is 10%.
What is the Net Income forecast for Qiagen NV?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 5 years is 10%.
